Genmab — April 2018
-
Safety and efficacy of daratumumab in dialysis-dependent renal failure secondary to multiple myeloma - in Haematologica journal - http://www.haematologica.org/content/early/2018/04/03/haematol.2018.191122.full.pdf+html
-
Watch our new strategy progress film
http://www.genmab.com/about-us/strategy -
De 15 er:Other Indications
•Amyloidosis (Ph III)
•NKTCL, Nasal type
•Myelodysplastic syndromes
•NSCLC
•Colon cancer
•Virus associated tumors
•Membranoproliferative
glomerulonephritis
•Waldenstrom
macroglobulinemia
•Prostate cancer
•Breast cancer
•Renal cancer / Bladder cancer
•CLL
•NHL
•AML
•ALL -
Ingen tvivl om at Dara i solide bliver en gamechanger. , også Dara sc. , men mon ikke at TV bliver en lige så stor andenhånds blockbuster for Genmab og Sgen . Der er virkelig meget for nuværende der kan rykke kursen ( både op og ned ) . Er mindst lige så spændt på hvad tallene siger for Dara ROW efter et fuldt Q . Håber på positive nyheder.

-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind